Nrf2 alleviates radiation-induced rectal injury by inhibiting of necroptosis

Yiqing Xu,Wenzhi Tu,Di Sun,Xuming Chen,Yulong Ge,Shengyu Yao,Bing Li,Zhenbo Zhang,Yong Liu
DOI: https://doi.org/10.1016/j.bbrc.2021.03.004
IF: 3.1
2021-01-01
Biochemical and Biophysical Research Communications
Abstract:Radiation-induced rectal injury is one of the common side effects of pelvic radiation therapy. This study aimed to explore the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in this process. In vivo, knockout (KO) of Nrf2 led to aggravated radiation-induced histological changes in the rectums. In vitro, interference or overexpression of Nrf2 resulted in enhanced or reduced radiosensitivity in human intestinal epithelial crypts (HIEC) cells, respectively. A potential relationship between Nrf2 and necroptosis was identified using RNA sequencing (RNA-seq) and western blotting (WB), which showed that necroptosis-related proteins were negatively correlated with Nrf2. Upon treatment with necrostatin-1 (Nec-1), the increased radiosensitivity, decreased cell viability, increased gamma H2AX foci formation, and decreased mitochondrial membrane potential (MMP) in Nrf2-interfered HIEC cells were alleviated. A significant recovery in morphological alterations was also observed in Nrf2 KO mice administered with Nec-1. Taken together, our results highlight the important protective effect of Nrf2 in radiation-induced rectal injury through the inhibition of necroptosis, and the physiological significance of necroptosis in radiation-induced rectal injury. (C) 2021 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?